Sotera Health Company (SHC) Q3 2026 earnings results
Sotera Health Company (SHC) reported Q3 2026 results on Nov 3, 2026, 8:11:42 AM ET: adjusted EPS $0.29 vs. $0.27 expected (beat by 8.0%); revenue $324.89M vs. $319.88M expected (beat by 1.6%). Outlook: Full-year 2026 net revenues growth outlook of 5.25% - 6.75% and Adjusted EBITDA growth outlook of 5.75% - 7.25% reaffirmed.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (adjusted, diluted) | $0.29 | $0.27 | Beat by 8.0% |
| Revenue | $324.89M | $319.88M | Beat by 1.6% |
Analyst estimate: the average forecast before the release.
Source
Figures from the SEC 8-K filing, released Nov 3, 2026, 8:11:42 AM ET. Nexqual published them 78 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 4.4% from $311.31M.
Stock reaction
The results came out before the market opened. SHC closed at $16.03 on November 3, 2026, down 9.6% from its $17.74 close on November 2, 2026 before the results.
Questions and answers
Did Sotera Health Company beat earnings expectations?
Yes. Sotera Health Company reported adjusted EPS of $0.29 against an average analyst estimate of $0.27 (beat by 8.0%), and revenue of $324.89M against $319.88M expected (beat by 1.6%).
What were Sotera Health Company's Q3 2026 earnings and revenue?
adjusted diluted EPS of $0.29 and revenue of $324.89M. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 4.4% from $311.31M.
When did Sotera Health Company report Q3 2026 earnings?
Nov 3, 2026, 8:11:42 AM ET, in an SEC 8-K filing (Item 2.02).
How did SHC stock react to the earnings?
The results came out before the market opened. SHC closed at $16.03 on November 3, 2026, down 9.6% from its $17.74 close on November 2, 2026 before the results.
What did Sotera Health Company say about its outlook?
Full-year 2026 net revenues growth outlook of 5.25% - 6.75% and Adjusted EBITDA growth outlook of 5.75% - 7.25% reaffirmed.
More on SHC
SHC stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings November 3, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built November 4, 2026 at 10:47 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 4, 2026 at 10:47 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt